DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL)

European Journal of Haematology, Supplement

Volumn 61, Issue 64, 2001, Pages 41-45

  Coleman, M ^a   Leonard, J ^a   Shuster, M W ^a   Kaufman, T P ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Continuous infusion; Cytoreduction; DICE; Ifosfamide; Salvage chemotherapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; DICE PROTOCOL;

ADULT; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; MALE; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; AGE; AGED; ARTICLE; DRUG RESISTANCE; METHODOLOGY; MIDDLE AGED; RECURRENT DISEASE; REMISSION; SALVAGE THERAPY; SEX DIFFERENCE;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; SEX FACTORS;

EID: 0034743474     PISSN: 09024506     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Advances in chemotherapy for large cell lymphoma
2. COPBLAM III: Infusional combination chemotherapy for diffuse large-cell lymphoma
3. CODBLAM IV chemotherapy for large cell lymphoma
4. Ifosfamide in the treatment of high grade recurrent non-Hodgkin' s lymphoma
5. Ifosfamide continuous infusion plus etoposide in the treatment of elderly patients with aggressive lymphoma: A Phase II Study
6. Ifosfamide therapy for hematologic malignancies in patients refractory to prior treatment
7. Ifosfamide by continuous infusion to prevent encephalopathy
8. Ifosfamide in the treatment of non-Hodgkin's lymphoma
9. Etoposide in leukemia, lymphoma, and bone marrow transplantation
10. Etoposide as a single agent and in combination with cis-platinum for malignant lymphoma
11. Phase II trial of cis-dichlorodiammineplatinum II in advanced malignant lymphoma. A study of Cancer and Leukemia Group B
12. Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide, and cis-platin
13. Dexamethasone, etoposide ifosfamide, cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma
14. DICE (dexamethasone, ifosfamide, cisplatin, etoposide) as salvage therapy in non-Hodgkin's lymphomas
15. Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma
16. Ifosfamide, carboplatin, and etoposide: A new regimen with a broad spectrum of activity
17. Semantics and the chemotherapy of Hodgkin' s disease-resistance is not relapse: Alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment